| Nov 14 |
NRx Pharmaceuticals reports Q3 results
|
| Nov 14 |
NRx Pharmaceuticals (NASDAQ:NRXP) Reports Third Quarter and Year to Date 2024 Financial Results and Provides Business Update
|
| Nov 14 |
NRx Pharmaceuticals files to sell 3.3M shares of common stock for holders
|
| Nov 13 |
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reschedules Conference Call to Discuss Third Quarter and Year to Date 2024 Financial Results to November 18, 2024
|
| Oct 31 |
NRx Pharmaceuticals added to Emerging Growth Conference 76 on October 31 and Update to Schedule
|
| Oct 30 |
HOPE Therapeutics and NRx Pharmaceuticals to buy Florida Interventional Psychiatry Clinics
|
| Oct 30 |
HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announce Signing of a Letter of Intent to Acquire its First Florida Interventional Psychiatry Clinics
|
| Oct 23 |
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) and HOPE Therapeutics, Inc. Announce Participation at the ThinkEquity Conference October 30, 2024
|
| Oct 21 |
NRx started at buy by EF Hutton, cites suicide prevention focus
|
| Oct 12 |
NRx Pharmaceuticals Leadership Shift and Strategic Governance Decisions
|
